Richard S. Levy - Nov 7, 2024 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Nov 7, 2024
Transactions value $
$0
Form type
4
Date filed
11/12/2024, 04:35 PM
Previous filing
Nov 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +1.3K +10.1% 14.2K Nov 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Restricted Share Units Award $0 +1.3K $0.00 1.3K Nov 7, 2024 Class A Ordinary Shares 1.3K Direct F1, F2
transaction KNSA Restricted Share Units Options Exercise $0 -1.3K -100% $0.00 0 Nov 7, 2024 Class A Ordinary Shares 1.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 The RSUs vested immediately upon grant on November 7, 2024; there was no expiration date for the RSUs.